We’re proud that Spiro PD may help people with respiratory conditions not only protect their lung health during this flu epidemic, but also help educate, motivate, or just remind them to get a flu vaccination.
Allentown, Pennsylvania (PRWEB) January 23, 2013
The flu epidemic now affects people in all 50 states and the District of Columbia. The young, the elderly, and those who already have lung conditions are hit hardest. The Centers for Disease Control recommends the vaccination for people who are at higher risk for flu complications due to a chronic pulmonary condition, such as asthma or COPD. And the US Preventive Services Task Force has stated that evidence suggests influenza vaccination reduces COPD exacerbations. The USPTF, as far back as 2009, has also theorized that spirometry may help people with COPD, asthma, emphysema, cystic fibrosis, or a lung transplant closely monitor their lung health and help increase flu vaccination rates.
A recently introduced solution for monitoring lung health is Spiro PD Personal Spirometer. People with chronic breathing problems associated with asthma, COPD, bronchitis, emphysema, cystic fibrosis, or a lung transplant are using Spiro PD to track lung function trends to help prevent possible complications from colds and the flu.
As the world’s first personal spirometer, Spiro PD empowers people with respiratory conditions to easily and accurately monitor their breathing any time and anywhere: at home, work, school, play, or while traveling.
Spiro PD helps patients anticipate and prevent respiratory disease exacerbations, which may reduce expensive emergency room visits and hospital stays. It also helps prevent readmissions, so hospitals can avoid costly Medicare penalties.
According to a Johns Hopkins University study, home spirometry detected a decline in lung function 16 days before patients felt symptoms and sought medical care.(1) Spiro PD’s ability to note early detection of decreased lung function can catch problems before they worsen and keep chronic respiratory patients out of hospitals.
Plus, the innovative telemedicine feature of Spiro PD permits patients to easily upload their data to their computer and share it with doctors between office visits. The telemedicine feature is proving particularly valuable for people who are physically challenged or live a long distance from their doctors. This feature also may be popular at a time when, due to an overload of flu cases, physicians are seeing only the sickest patients. And only if necessary should people risk exposure by visiting the doctor or hospital.
Wayne Meng, Founder, Chief Executive Officer, and President of PMD Healthcare, the maker of Spiro PD, states, “We’re proud that Spiro PD may help people with respiratory conditions not only protect their lung health during this flu epidemic, but also help educate, motivate, or just remind them to get a flu vaccination.”
In the United States, the cold and flu season is considered October through May, usually peaking in February.(2,3) Each year, colds and flu usually account for 200,000 hospitalizations and 41,000 deaths in this country.(4) People with respiratory conditions, including asthma, COPD, bronchitis, emphysema, cystic fibrosis, and a lung transplant, are particularly susceptible, and can develop life-threatening complications including pneumonias and acute respiratory distress syndrome.(5)
For more information about all the advantages that Spiro PD offers people with respiratory conditions, please visit http://www.SpiroPD.com.
About Spiro PD
“Spiro" stands for spirometer, a device used to measure air entering and leaving the lungs; "PD" stands for personal device. Spiro PD is the first personal spirometer that enables people with lung diseases – COPD, asthma, CF, and lung transplants – to easily and accurately monitor their breathing anytime and anywhere.
Spiro PD tracks lung function trends to help patients anticipate and prevent respiratory disease exacerbations, which helps reduce expensive emergency room visits and hospital stays. According to a study conducted at Johns Hopkins University, home spirometry detected decreased lung function 16 days before patients felt symptoms and sought medical care.(1)
Spiro PD enhances medication adherence. The medication alarm helps patients remember to take their medicine. The medication history provides a time stamp to show doctors that patients have been following their therapy.
Spiro PD also allows patients to set alarms reminding them to perform spirometry tests and do breathing exercises. Plus, patients can quickly upload data to their computer and share it with their doctor.
Spiro PD is cleared by the FDA for home use by the patient to test lung function in children, adolescents, and adults. Many insurance companies cover the cost of Spiro PD.
Spiro PD meets American Thoracic Society (ATS) and European Respiratory Society (ERS) standards. Spiro PD is also certified with the CE mark for the European Union (EU).
For more information, visit http://www.SpiroPD.com.
About PMD Healthcare, Inc.
PMD Healthcare, manufacturer of Spiro PD, is dedicated to creating innovative, easy-to-use, portable, and affordable personal medical devices that empower people worldwide to improve their healthcare and quality of life. For more information about PMD Healthcare and Spiro PD, please visit http://www.SpiroPD.com.
1. West NE, Boyle MP, Mogayzel PJ, Riekert KA, Lechtzin N. The ability of home spirometry and symptom monitoring to predict exacerbations in cystic fibrosis. Pediatric Pulmonology 2009; Vol. 34, S32 “Poster Session Abstract” poster 376.
2. CDC Questions and Answers 2010-01-27, Retrieved 2010-08-10.
3. CDC: The Flu Season. http://www.cdc.gov/flu/about/season/flu-season.htm. Retrieved 11-22-12.
4. Molinari, Ortega-Sanchez, Messonnier, Thompson, Wortley, Weintraub, Bridges. The annual impact of seasonal inﬂuenza in the US: Measuring disease burden and costs doi:10.1016/j.vaccine.2007.03.046 PMID 17544181.
5. Flu Season Overview North Carolina Immunization portal. Retrieved 11-22-12.